|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Endocrinology, Carl T. Hayden Veterans Affairs Medical Center, Phoenix, Arizona
Submitted 11 June 2008 ; accepted in final form 4 January 2009
We examined the intracellular metabolic fate of plasma glucose during a hyperglycemic clamp in impaired glucose-tolerant (IGT; n = 21) and normal glucose-tolerant subjects (n = 10) using a combination of [3-3H]glucose infusion with measurement of [3H]water formation and indirect calorimetry. IGT was associated with
35% reduced first-phase insulin responses, normal second-phase insulin response, and 25–30% reduced insulin sensitivity, resulting in
35% reduced plasma glucose disposal. This was coupled with
55% reduced storage of plasma glucose (P < 0.01) and
15–20% reduced glycolysis of plasma glucose (P < 0.03), accounting for
75 and 25% of the reduction in glucose disposal, respectively. Decreased glucose oxidation accounted for virtually all the decrease in glycolysis. Therefore, nonoxidative glycolysis of plasma glucose in IGT was similar to that in NGT (P > 0.9) and accounted for an increased proportion of systemic glucose disposal (P < 0.05). We conclude that, in IGT, decreased disposal of plasma glucose involves mainly decreased glycogen synthesis and to a lesser extent decreased glycolysis, which is accounted for by decreased glucose oxidation. An increased proportion of plasma glucose hence undergoes nonoxidative glycolysis, representing a novel early abnormality in the pathogenesis of T2DM.
glucose oxidation; glycogen synthesis; glycolysis
This article has been cited by other articles:
![]() |
E. L. Dillon and M. Sheffield-Moore Novel Noninvasive Breath Test Method for Screening Individuals at Risk for Diabetes: Response to Davidson Diabetes Care, July 1, 2009; 32(7): e89 - e89. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |